ATRA vs L · rev $128.9M vs P/E 14, rev $18.45B
Atara Biotherapeutics Inc (ATRA) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
ATRA currently screens at market cap $87.1M. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the ATRA and L stock pages for the full models.
Not investment advice.